Hyperuricemia and risk of stroke: a systematic review and meta-analysis
- PMID: 19565556
- PMCID: PMC2714267
- DOI: 10.1002/art.24612
Hyperuricemia and risk of stroke: a systematic review and meta-analysis
Abstract
Objective: To assess the association between hyperuricemia and risk of stroke incidence and mortality because hyperuricemia is hypothesized to be a risk factor for stroke and other cardiovascular disease, but, to date, results from observational studies are conflicting.
Methods: A systematic review and meta-analysis were conducted. Studies were identified by searching major electronic databases using the Medical Subject Headings and keywords without restriction in languages. Prospective cohort studies were included only if they contained data on stroke incidences or mortalities related to serum uric acid levels in adults. Pooled risk ratios (RRs) for the association of stroke incidence and mortality with serum uric acid levels were calculated.
Results: A total of 16 studies including 238,449 adults were eligible and abstracted. Hyperuricemia was associated with a significantly higher risk of both stroke incidence (6 studies; RR 1.41, 95% confidence interval [95% CI] 1.05, 1.76) and mortality (6 studies; RR 1.36, 95% CI 1.03, 1.69) in our meta-analyses of unadjusted study estimates. Subgroup analyses of studies adjusting for known risk factors such as age, hypertension, diabetes mellitus, and cholesterol still showed that hyperuricemia was significantly associated with both stroke incidence (4 studies; RR 1.47, 95% CI 1.19, 1.76) and mortality (6 studies; RR 1.26, 95% CI 1.12, 1.39). The pooled estimate of multivariate RRs did not differ significantly by sex.
Conclusion: Hyperuricemia may modestly increase the risks of both stroke incidence and mortality. Future research is needed to determine whether lowering uric acid level has any beneficial effects on stroke.
Figures




Similar articles
-
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.Arthritis Care Res (Hoboken). 2010 Feb;62(2):170-80. doi: 10.1002/acr.20065. Arthritis Care Res (Hoboken). 2010. PMID: 20191515 Free PMC article.
-
Systematic review on urine albumin testing for early detection of diabetic complications.Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300. Health Technol Assess. 2005. PMID: 16095545
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
Cited by
-
Possible burden of hyperuricaemia on mortality in a community-based population: a large-scale cohort study.Sci Rep. 2021 Apr 26;11(1):8999. doi: 10.1038/s41598-021-88631-8. Sci Rep. 2021. PMID: 33903733 Free PMC article.
-
Compliance of Primary Care Providers With Gout Treatment Recommendations-Lessons to Learn: Results of a Nationwide Survey.Front Med (Lausanne). 2020 Jun 2;7:244. doi: 10.3389/fmed.2020.00244. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32582733 Free PMC article.
-
Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study Protocol.High Blood Press Cardiovasc Prev. 2023 Nov;30(6):573-583. doi: 10.1007/s40292-023-00607-z. Epub 2023 Nov 30. High Blood Press Cardiovasc Prev. 2023. PMID: 38030852 Free PMC article.
-
Gout and dementia in the elderly: a cohort study of Medicare claims.BMC Geriatr. 2018 Nov 14;18(1):281. doi: 10.1186/s12877-018-0975-0. BMC Geriatr. 2018. PMID: 30428833 Free PMC article.
-
Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis.BMC Nephrol. 2019 Jan 14;20(1):18. doi: 10.1186/s12882-018-1143-7. BMC Nephrol. 2019. PMID: 30642279 Free PMC article.
References
-
- Wilcox W, Khalaf A, Weinberger A, et al. Solubility of uric acid and monosodium urate. Med Biol Eng. 1972;10:522–531. - PubMed
-
- Becker M, Schumacher HJ, Wortmann R, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005 December;353:2450–2461. - PubMed
-
- Wortmann R. Gout and hyperuricemia. Curr Opin Rheumatol. 2002;14:281–286. - PubMed
-
- Baker J, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, where do they leave us? Am J Med. 2005;118:816–826. - PubMed
-
- Becker M, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin N Am. 2006;32:275–293. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical